Detection of fetal fibronectin in twin pregnancies in relation to gestational age.
BACKGROUND
The presence of fetal fibronectin in the cervix or vagina has been investigated as a possible marker for the risk of preterm birth. Fetal fibronectin in cervical fluid can provide direct evidence of pathologic changes at the interface of fetal and maternal tissues.


OBJECTIVE
To evaluate the presence of fetal fibronectin as a predictor of premature delivery in twin pregnancies in relation to gestational age.


METHODS
Accuracy study.


METHODS
University referral unit.


METHODS
52 pregnant women with twin pregnancies and gestational age of between 24 and 34 weeks.


METHODS
Sensitivity, specificity, predictive values and relative risk ratios of the correlation between fetal fibronectin and preterm birth before 34 and 37 weeks using an immediate-reading membrane test on cervicovaginal secretions obtained from participants.


RESULTS
The sensitivity varied between 66.7% and 85.7%, whereas the specificity was from 58.3% to 81.8% according to gestational age at the time of sampling. The relative risk of spontaneous preterm birth after a positive fetal fibronectin test, as compared with a negative fetal fibronectin test, rose from 2.8 at 24-26 weeks to 4.1 at 27-30 weeks. Analyses of the risk of delivery before 34 weeks were not statistically significant.


CONCLUSIONS
Fetal fibronectin in the cervicovaginal secretions of patients with twin pregnancies is a useful tool for the early identification of twin pregnancies likely to deliver before 37 weeks. However, the clinical value of the fibronectin test is limited because of low indices for prediction of delivery before 34 weeks. The best period for performing the fetal fibronectin test in twin pregnancies to predict preterm delivery is between 27 and 30 weeks.
Oliveira
T A
TA
Hospital Maternidade Leonor Mendes de Barros, São Paulo, Brazil.
Carvalho
C M
CM
de Souza
E
E
Mariani-Neto
C
C
Camano
L
L
D015415:Biomarkers / Q000032:analysis; D005260:Female; D005353:Fibronectins / Q000032:analysis*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000175:diagnosis*; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011247:Pregnancy; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D014427:Twins; D014626:Vaginal Smears
D015415:Biomarkers; D005353:Fibronectins